← Eichor
Study identifier: NCT06803628 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Contribution of Point of Care Ultrasound by the Emergency Physician to Rule Out the Small Bowel Obstruction: a Diagnostic, Multicenter Study

Condition: Small Bowel Obstruction  ·  Sponsor: Nantes University Hospital

PhaseN/A
Planned participants667
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Small Bowel Obstruction (SBO) is a frequent pathology in the emergency department (ED). Diagnosis is currently based on abdominal CT scan (CT). Moreover, CT is warranted to determine the therapeutic strategy in patients with SBO which could include medical treatment; surgical intervention or both. However, CT is associated with drawbacks such as radiation exposure, increased cost and ED length-of-stay. In a prospective observational study, a SBO was excluded by CT in 45% \[95%CI: 37-53\] of patients. There is, thus, a need for improving the appropriateness of CT-scan for suspected SBO. A recent meta-analysis showed that Point of care ultrasound (POCUS) had a good diagnostic accuracy (sensitivity 83% \[95%CI 71.7%-90.4%\]), specificity 93% \[95%CI 55.3%-99.3%\]). Another meta-analysis found rather similar results (sensitivity 83% \[(95% CI 89.0% to 94.7%\], specificity 96,6% \[95% CI 88.4% to 99.1%\]). In order to improve the negative predictive value of POCUS for its implementation as a rule-out strategy, CHU of Nantes emergency unit studied the combination of POCUS with Gestalt pre-test probability of SBO determined by the emergency physician. This SBO probability classified the patients as low, moderate or high risk of SBO. In patients with low or moderate Gestalt probability, CHU of Nantes emergency unit found that this combined strategy had a sensitivity of 100% \[95% CI: 88-100\] and NPV 100% \[92-100%\]. By (i) focusing on patients with a low or moderate Gestalt cli…

This description comes directly from the study's public registry record.

Talk to the study team

Philippe LE CONTE Professor LE CONTE, Professor  ·  0240083934  ·  philippe.leconte@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (18)

Chu Clermont-Ferrand Hopital Gabriel MontpiedClermont-Ferrand, France, FranceRecruiting
Ghem Groupe Hospitalier Eaubonne Montmorency Simone VeilEaubonne, France, FranceRecruiting
CHD VendéeLa Roche-sur-Yon, France, FranceRecruiting
CHD Vendée, LuçonLuçon, France, FranceRecruiting
Ap-Hm Hopital La TimoneMarseille, France, FranceRecruiting
Hôpital NordMarseille, France, FranceWithdrawn
Ghsif Groupe Hospitalier Sud Ile de Franc _ Ch MelunMelun, France, FranceRecruiting
CHD Vendée, MontaiguMontaigu, France, FranceRecruiting
CHU NantesNantes, France, FranceRecruiting
Le ConfluentNantes, France, FranceRecruiting
CHU CAREMEAU - NimesNîmes, France, FranceRecruiting
AP-HP Est Parisien _ ST-ANTOINEParis, France, FranceRecruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06803628